Document is current
Any future updates will be listed below
-
Authors
Reason, Ellery H.
Aiduk, Michael D.
Nash, Amanda L.
McDuff, Susan G. R.
Renner, Derrick
Kollipara, Rahul Krishna
Satta, Sandro
Velichko, Sharlene
Kalashnikova, Ekaterina
Rodriguez, Angel A.
Liu, Minetta C.
Strickler, John H.
Grilley-Olson, Juneko E.
Rosenberger, Laura H. https://orcid.org/0000-0002-6829-6747
- License Information
-
More Information
Article History
First Online: 18 August 2025
Disclosure
: E.H.R., M.D.A., A.L.N., S.G.R.M., and L.H.R. have nothing to disclose. J.H.S.—consultant or advisory role (personal): Abbvie, Amgen, Astellas, AstraZeneca, Bayer, BeOne, BMS, Cytovation, Daiichi-Sankyo, Eli Lilly, GE Healthcare, GSK, Incyte, Ipsen, Johnson and Johnson, Jazz Pharmaceuticals, Leap, Merck, Natera, Pfizer, Quanta Therapeutics, Roche/Genentech, Regeneron, Sanofi, Taiho, Takeda, Xilio Therapeutics, and Triumvira Immunologics (stock options); research funding or contracted research (Institution): Abbvie, Amgen, Apollo Therapeutics, Bayer, BeOne, Daiichi-Sankyo, Eli Lilly, GSK, Leap Therapeutics, Novartis, Pfizer, Quanta Therapeutics, Revolution Medicines, Roche/ Genentech, and JEGO (research): Polaris pharmaceuticals, Inhibrx, Boehringer Ingelheim, Abbisko, (consulting): Deciphera, Ipsen. D., S.V., A.A.R., M.C.L., and C.C.P. are employees of Natera, Inc. and have stock in Natera, Inc.
